Notably, the tumor suppressor role of DY131 significantly inhibited the expression of PKM2 in ESCC cells, confirming that the ESRRG agonist DY131 inhibited tumor proliferation by acting on the glycolysis pathway (Additional file 1: Fig. S7C). The gene discussed is PKM; the disease is esophageal squamous cell carcinoma.